TrialFit.Ai is an integrated, AI-powered platform that accurately matches patients to the most suitable therapies and clinical trials, whether approved or investigational. By leveraging patient clinical data from electronic health records (EHRs/EMRs), the platform constructs digital twins and aligns them with therapies using disease models trained on real-world multimodal data.
TrialFit.Ai expands access to clinical trials by moving beyond rigid, narrow matching criteria, ensuring that patients are considered for studies that genuinely align with their individual clinical profiles. Its streamlined, data-driven matching accelerates trial enrollment and improves recruitment efficiency. Most importantly, by prioritizing therapies based on predicted treatment response and disease progression, TrialFit.Ai supports personalized strategies designed to improve long-term patient outcomes.
TrialFit.Ai integrates advanced AI, disease modeling, and real-world clinical data to match patients with the right therapies and clinical trials.
Patient data from EHRs and EMRs is transformed into rich clinical profiles—digital twins—that capture each individual’s disease characteristics with precision.
TrialFit.Ai leverages advanced disease models built using machine learning and foundation models trained on public datasets. These patient-agnostic models draw from thousands of cases and are optimized to predict drug response, disease progression, and long-term outcomes.
Digital twins are mapped onto the disease model space to evaluate clinical similarities. This comparison helps identify therapies most likely to deliver meaningful, long-term results for each patient.
Matched therapies are linked to relevant clinical trials through BioThinkHub—ThinkBio.Ai®’s integrated knowledge platform. BioThinkHub aggregates global trial registries, scientific literature, and drug databases to recommend trials best suited to each patient profile.
Smarter therapy decisions. Faster trial access. Better patient outcomes
Advanced algorithms transform EHR and EMR data into rich patient profiles, analyzing complex clinical features to identify therapies with the highest likelihood of success. Patients are matched to treatments using disease-specific model projections for optimal outcomes.
Real-time digital twins reflect each patient’s evolving clinical state. Built from actual medical data, these dynamic models simulate disease trajectories and predict therapy response—enabling truly personalized care decisions.
Trained on data from thousands of patients, our disease models offer a scalable, unbiased foundation for therapy guidance. They’re fine-tuned to forecast drug response, disease progression, and long-term outcomes across conditions.
Patients are instantly connected to relevant clinical trials. The platform scans global trial databases, literature, and drug registries—filtering by eligibility, location, and therapeutic fit—to surface the best opportunities in real time
TrialFit.Ai bridges the gap between care and trial enrollment. It automates matching within existing workflows, reduces delays, and expands access to investigational therapies, ensuring every patient gets the best next step.
Designed for enterprise deployment, TrialFit.Ai integrates with major EHR systems and supports disease-specific customization. Built to meet global data privacy standards, including HIPAA, with security and compliance at its core.
Would you like us to get in touch with you? Fill up the form & we will reach out to you